Skip to main content
See every side of every news story
Published • loading... • Updated

Spain Already Manufactures the New Pill Against Obesity: It Is Taken Once a Day, but Still Cannot Be Bought in the Canary Islands

Summary by laprovincia.es
Spain already manufactures one of the most revolutionary anti-obesity drugs, but patients from the Canary Islands and the rest of the national territory will still have to wait to access it. The pharmaceutical plant Lilly in Alcobendas (Madrid) has begun to produce orforglipron, an oral pill that will be exported to 120 countries. At the moment, the drug – traded under the name of Fondayo – is authorized in the United States, the United Arab Emi…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

Spain already manufactures one of the most revolutionary anti-obesity drugs, but patients from the Canary Islands and the rest of the national territory will still have to wait to access it. The pharmaceutical plant Lilly in Alcobendas (Madrid) has begun to produce orforglipron, an oral pill that will be exported to 120 countries. At the moment, the drug – traded under the name of Fondayo – is authorized in the United States, the United Arab Emi…

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

laprovincia.es broke the news on Tuesday, November 3, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal